3,307
Views
197
CrossRef citations to date
0
Altmetric
Review

All you need is light

Antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease

, , , , , & show all
Pages 509-520 | Received 18 Jul 2011, Accepted 26 Aug 2011, Published online: 01 Nov 2011

References

  • Sigerist H. The Great Doctors 1971; New York Dover Publications 371
  • Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 2000; 16:3 - 10; PMID: 11137402; http://dx.doi.org/10.1016/S0924-8579(00)00299-5
  • Kraus CN. Low hanging fruit in infectious disease drug development. Curr Opin Microbiol 2008; 11:434 - 438; PMID: 18822387; http://dx.doi.org/10.1016/j.mib.2008.09.009
  • Vicente M, Hodgson J, Massidda O, Tonjum T, Henriques-Normark B, Ron EZ. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?. FEMS Microbiol Rev 2006; 30:841 - 852; PMID: 17064283; http://dx.doi.org/10.111/j.1574-6976.2006.00038.x
  • Butler MS, Buss AD. Natural products-the future scaffolds for novel antibiotics?. Biochem Pharmacol 2006; 71:919 - 929; PMID: 16289393; http://dx.doi.org/10.1016/j.bcp.2005.10.012
  • Nicolau DP. Current challenges in the management of the infected patient. Curr Opin Infect Dis 2011; 24:1 - 10; PMID: 21200179; http://dx.doi.org/10.1097/01.qco.0000393483.10270.ff
  • Norrby SR, Nord CE, Finch R. Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 2005; 5:115 - 119; PMID: 15680781
  • Cornaglia G, Giamarellou H, Rossolini GM. Metallobeta-lactamases: a last frontier for beta-lactams?. Lancet Infect Dis 2011; 11:381 - 393; PMID: 21530894; http://dx.doi.org/10.1016/S1473-3099(11)70056-1
  • Turner M. Microbe outbreak panics Europe. Nature 2011; 474:137; PMID: 21654775; http://dx.doi.org/10.1038/474137a
  • Raab O. Ueber diewirkung fluoreszierender stoffe auf infusori. Z Biol 1900; 39:524 - 536
  • Mitton D, Ackroyd R. A brief overview of photodynamic therapy in Europe. Photodiagnosis Photodyn Ther 2008; 5:103 - 111; PMID: 9356640; http://dx.doi.org/10.1016/j.pdpdt.2008.04.004
  • Dai T, Huang YY, Hamblin MR. Photodynamic therapy for localized infections—state of the art. Photodiagn Photodyn Ther 2009; 6:170 - 188; http://dx.doi.org/10.1016/j.pdpdt.2009.10.008
  • Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3:380 - 387; PMID: 12724736; http://dx.doi.org/10.1038/nrc1071
  • Hunt DW. Rostaporfin (Miravant Medical Technologies). IDrugs 2002; 5:180 - 186; PMID: 12861479
  • Nitzan Y, Gutterman M, Malik Z, Ehrenberg B. Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol 1992; 55:89 - 96; PMID: 1534909; http://dx.doi.org/10.1111/j.1751-097.1992.tb04213.x
  • Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991; 54:659; PMID: 1798741; http://dx.doi.org/10.1111/j.1751-097.1991.tb02071.x
  • Tanielian C, Mechin R, Seghrouchni R, Schweitzer C. Mechanistic and kinetic aspects of photosensitization in the presence of oxygen. Photochem Photobiol 2000; 71:12 - 19; PMID: 10649884; http://dx.doi.org/10.1562/0031-8655(2000)071<0012:MAKAOp>2.0.CO;2
  • Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B 1997; 39:1 - 18; PMID: 9210318; http://dx.doi.org/10.1016/S1011-1344(96)07428-3
  • Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12:1161 - 1208; PMID: 15892631; http://dx.doi.org/10.2174/0929867053764635
  • Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol and ascorbate. Arch Biochem Biophys 1993; 300:535 - 543; PMID: 8434935; http://dx.doi.org/10.1006/abbi.1993.1074
  • Singleton DA, Hang C, Szymanski MJ, Meyer MP, Leach AG, Kuwata KT, et al. Mechanism of ene reactions of singlet oxygen. A two-step no-intermediate mechanism. J Am Chem Soc 2003; 125:1319 - 1328; PMID: 12553834; http://dx.doi.org/10.1021/ja027225p
  • Leach AG, Houk KN. Diels-Alder and ene reactions of singlet oxygen, nitroso compounds and triazolinediones: transition states and mechanisms from contemporary theory. Chem Commun (Camb) 2002; 1243 - 1255; PMID: 12109102; http://dx.doi.org/10.1039/b111251c
  • Wainwright M, Byrne MN, Gattrell MA. Phenothiazinium-based photobactericidal materials. J Photochem Photobiol B 2006; 84:227 - 230; PMID: 16713280;; http://dx.doi.org/10.1016/j.jphotobiol.2006.03.002
  • Takahashi PK, Toups HJ, Greenberg DB, Dimopoullos GT, Rusoff LL. Irradiation of Escherichia coli in the visible spectrum with a tunable organic-dye laser energy source. Appl Microbiol 1975; 29:63 - 67; PMID: 1089163
  • Huang L, Huang YY, Mroz P, Tegos GP, Zhiyentayev T, Sharma SK, et al. Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob Agents Chemother 2010; 54:3834 - 3841; PMID: 20625146; http://dx.doi.org/10.1128/AAC.00125-10
  • Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004; 1:279 - 293; http://dx.doi.org/10.1016/S1572-1000(05)00007-4
  • Schäfer M, Schmitz C, Facius R, Horneck G, Milow B, Funken KH, et al. Systematic study of parameters influencing the action of Rose Bengal with visible light on bacterial cells: comparison between the biological effect and singlet-oxygen production. Photochem Photobiol 2000; 71:514 - 523; PMID: 10818781; http://dx.doi.org/10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2
  • Kubin A, Wierrani F, Jindra RH, Loew HG, Grunberger W, Ebermann R, et al. Antagonistic effects of combination photosensitization by hypericin, mesotetrahydroxyphenylchlorin (mTHPC) and photofrin II on Staphylococcus aureus. Drugs Exp Clin Res 1999; 25:13 - 21; PMID: 10337500
  • Harris F, Chatfield LK, Phoenix DA. Phenothiazinium based photosensitisers-photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr Drug Targets 2005; 6:615 - 627; PMID: 16026282; http://dx.doi.org/10.2174/1389450054545962
  • Tegos GP, Demidova TN, Arcila-Lopez D, Lee H, Wharton T, Gali H, et al. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 2005; 12:1127 - 1135; PMID: 16242655; http://dx.doi.org/10.1016/j.chembiol.2005.08.014
  • Huang L, Terakawa M, Zhiyentayev T, Huang YY, Sawayama Y, Jahnke A, et al. Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine 2010; 6:442 - 452; PMID: 19914400; http://dx.doi.org/10.1016/j.nano.2009.10.005
  • Fisher WG, Partridge WP Jr, Dees C, Wachter EA. Simultaneous two-photon activation of type-I photodynamic therapy agents. Photochem Photobiol 1997; 66:141 - 155; PMID: 9277135; http://dx.doi.org/10.1111/j.1751-097.1997.tb08636.x
  • Bulina ME, Chudakov DM, Britanova OV, Yanushevich YG, Staroverov DB, Chepurnykh TV, et al. A genetically encoded photosensitizer. Nat Biotechnol 2006; 24:95 - 99; PMID: 16369538; http://dx.doi.org/10.1038/nbt1175
  • Oriel S, Nitzan Y. Photoinactivation of Candida albicans by its own endogenous porphyrins. Curr Microbiol 2010; 60:117 - 123; PMID: 19795168; http://dx.doi.org/10.1007/s00284-009-9514-8
  • MacLean M, Macgregor SJ, Anderson JG, Woolsey GA. The role of oxygen in the visible-light inactivation of Staphylococcus aureus. J Photochem Photobiol B 2008; 92:180 - 184; PMID: 18657991; http://dx.doi.org/10.1016/j.jphotobiol.2008.06.006
  • Minnock A, Vernon DI, Schofield J, Griffiths J, Parish JH, Brown SB. Mechanism of uptake of a cationic water-soluble pyridinium zinc phthalocyanine across the outer membrane of Escherichia coli. Antimicrob Agents Chemother 2000; 44:522 - 527; PMID: 10681312; http://dx.doi.org/10.1128/AAC.44.3.522-7.2000
  • Lazzeri D, Rovera M, Pascual L, Durantini EN. Photodynamic studies and photoinactivation of Escherichia coli using meso-substituted cationic porphyrin derivatives with asymmetric charge distribution. Photochem Photobiol 2004; 80:286 - 293; PMID: 15362952; http://dx.doi.org/10.1562/2004-03-08-RA-105.1
  • Bliss JM, Bigelow CE, Foster TH, Haidaris CG. Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob Agents Chemother 2004; 48:2000 - 2006; PMID: 15155191; http://dx.doi.org/10.1128/AAC.48.6.2000-6.2004
  • Lazarova G. Effect of glutathione on rose bengal photosensitized yeast damage. Microbios 1993; 75:39 - 43; PMID: 8377662
  • Bertoloni G, Rossi F, Valduga G, Jori G, Ali H, van Lier JE. Photosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios 1992; 71:33 - 46; PMID: 1406343
  • Tsai T, Chien HF, Wang TH, Huang CT, Ker YB, Chen CT. Chitosan augments photodynamic inactivation of gram-positive and gram-negative bacteria. Antimicrob Agents Chemother 2011; 55:1883 - 1890; PMID: 21282440; http://dx.doi.org/10.1128/AAC.00550-10
  • Coleman JJ, Okoli I, Tegos GP, Holson EB, Wagner FF, Hamblin MR, et al. Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol 2010; 5:321 - 332; PMID: 20099897; http://dx.doi.org/10.1021/cb900243b
  • DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010; 375:1557 - 1568; PMID: 20206987; http://dx.doi.org/10.1016/S0140-6736(09)61999-1
  • Gould IM. VRSA-doomsday superbug or damp squib?. Lancet Infect Dis 2010; 10:816 - 818; PMID: 21109164; http://dx.doi.org/10.1016/S1473-3099(10)70259-0
  • Chavers LS, Moser SA, Benjamin WH, Banks SE, Steinhauer JR, Smith AM, et al. Vancomycin-resistant enterococci: 15 years and counting. J Hosp Infect 2003; 53:159 - 171; PMID: 12623315; http://dx.doi.org/10.1053/jhin.2002.1375
  • Hajim KI, Salih DS, Rassam YZ. Laser light combined with a photosensitizer may eliminate methicillin-resistant strains of Staphylococcus aureus. Lasers Med Sci 2010; 25:743 - 748; PMID: 20552385; http://dx.doi.org/10.1007/s10103-010-0803-z
  • Soncin M, Fabris C, Busetti A, Dei D, Nistri D, Roncucci G, et al. Approaches to selectivity in the Zn(II)-phthalocyanine-photosensitized inactivation of wild-type and antibiotic-resistant Staphylococcus aureus. Photochem Photobiol Sci 2002; 1:815 - 819; PMID: 12656484; http://dx.doi.org/10.1039/b206554a
  • Tomé JP, Neves MG, Tomé AC, Cavaleiro JA, Soncin M, Magaraggia M, et al. Synthesis and antibacterial activity of new poly-S-lysine-porphyrin conjugates. J Med Chem 2004; 47:6649 - 6652; PMID: 15588101; http://dx.doi.org/10.1021/jm040802v
  • Schastak S, Ziganshyna S, Gitter B, Wiedemann P, Claudepierre T. Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength. PLoS ONE 2010; 5:116174; PMID: 20652031; http://dx.doi.org/10.1371/journal.pone.0011674
  • Schastak S, Gitter B, Handzel R, Hermann R, Wiedemann P. Improved photoinactivation of gram-negative and gram-positive methicillin-resistant bacterial strains using a new near-infrared absorbing mesotetrahydroporphyrin: a comparative study with a chlorine e6 photosensitizer photolon. Methods Find Exp Clin Pharmacol 2008; 30:129 - 133; PMID: 18560628; http://dx.doi.org/10.1358/mf.2008.30.2.1165448
  • Mantareva V, Kussovski V, Angelov I, W”hrle D, Dimitrov R, Popova E, et al. Non-aggregated Ga(III)-phthalocyanines in the photodynamic inactivation of planktonic and biofilm cultures of pathogenic microorganisms. Photochem Photobiol Sci 2011; 10:91 - 102; PMID: 21031201; http://dx.doi.org/10.1039/b9pp00154a
  • Dai T, Tegos GP, Zhiyentayev T, Mylonakis E, Hamblin MR. Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med 2010; 42:38 - 44; PMID: 20077489; http://dx.doi.org/10.1002/lsm.20887
  • Wainwright M, Phoenix DA, Gaskell M, Marshall B. Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp. J Antimicrob Chemother 1999; 44:823 - 825; PMID: 10590285; http://dx.doi.org/10.1093/jac/44.6.823
  • Xing B, Jiang T, Bi W, Yang Y, Li L, Ma M, et al. Multifunctional divalent vancomycin: the fluorescent imaging and photodynamic antimicrobial properties for drug resistant bacteria. Chem Commun (Camb) 2011; 47:1601 - 1603; PMID: 21109901; http://dx.doi.org/10.1039/c0cc04434b
  • Nordmann P, Naas T, Fortineau N, Poirel L. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol 2007; 10:436 - 440; PMID: 17765004; http://dx.doi.org/10.1016/j.mib.2007.07.004
  • Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007; 5:939 - 951; PMID: 18007677; http://dx.doi.org/10.1038/nrmicro1789
  • Tseng SP, Teng LJ, Chen CT, Lo TH, Hung WC, Chen HJ, et al. Toluidine blue O photodynamic inactivation on multidrug-resistant Pseudomonas aeruginosa. Lasers Surg Med 2009; 41:391 - 397; PMID: 19533759; http://dx.doi.org/10.1002/lsm.20765
  • Kussovski V, Mantareva V, Angelov I, Orozova P, W”hrle D, Schnurpfeil G, et al. Photodynamic inactivation of Aeromonas hydrophila by cationic phthalocyanines with different hydrophobicity. FEMS Microbiol Lett 2009; 294:133 - 140; PMID: 19431233; http://dx.doi.org/10.1111/j.1574-6968.2009.01555.x
  • Trannoy LL, Terpstra FG, de Korte D, Lagerberg JW, Verhoeven AJ, Brand A, et al. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation. Vox Sang 2006; 91:111 - 118; PMID: 16907871; http://dx.doi.org/10.1111/j.1423-0410.2006.00791.x
  • Jassal M, Bishai WR. Extensively drug-resistant tuberculosis. Lancet Infect Dis 2009; 9:19 - 30; PMID: 18990610; http://dx.doi.org/10.1016/S1473-3099(08)70260-3
  • Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; 372:1403 - 1409; PMID: 18723218; http://dx.doi.org/10.1016/S0140-6736(08)61204-0
  • O'Riordan K, Sharlin DS, Gross J, Chang S, Errabelli D, Akilov OE, et al. Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection. Antimicrob Agents Chemother 2006; 50:1828 - 1834; PMID: 16641456; http://dx.doi.org/10.1128/AAC.50.5.1828-34.2006
  • O'Riordan K, Akilov OE, Chang SK, Foley JW, Hasan T. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection. Photochem Photobiol Sci 2007; 6:1117 - 1123; PMID: 17914486; http://dx.doi.org/10.1039/b707962a
  • Wiegell SR, Kongshoj B, Wulf HC. Mycobacterium marinum infection cured by photodynamic therapy. Arch Dermatol 2006; 142:1241 - 1242; PMID: 16983024; http://dx.doi.org/10.1001/archderm.142.9.1241
  • Shih MH, Huang FC. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 2011; 52:223 - 229; PMID: 20811055; http://dx.doi.org/10.1167/iovs.10-5593
  • Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000; 19:1 - 8; PMID: 10706172; http://dx.doi.org/10.1007/s100960050001
  • Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003; 37:1172 - 1177; PMID: 14557960; http://dx.doi.org/10.1086/378745
  • Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome and overall cost of illness. Clin Infect Dis 1998; 27:781 - 788; PMID: 9798034; http://dx.doi.org/10.1086/514955
  • Chabrier-Roselló Y, Foster TH, Perez-Nazario N, Mitra S, Haidaris CG. Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother 2005; 49:4288 - 4295; PMID: 16189110; http://dx.doi.org/10.1128/AAC.49.10.4288-95.2005
  • Dovigo LN, Pavarina AC, Mima EG, Giampaolo ET, Vergani CE, Bagnato VS. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 2011; 54:123 - 130; PMID: 19889173; http://dx.doi.org/10.1111/j.1439-0507.2009.01769.x
  • Fuchs BB, Tegos GP, Hamblin MR, Mylonakis E. Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother 2007; 51:2929 - 2936; PMID: 17548495; http://dx.doi.org/10.1128/AAC.00121-07
  • Smijs TG, Pavel S, Talebi M, Bouwstra JA. Preclinical studies with 5,10,15-Tris(4-methylpyridinium)-20-phenyl-[21H,23H]-porphine trichloride for the photodynamic treatment of superficial mycoses caused by Trichophyton rubrum. Photochem Photobiol 2009; 85:733 - 739; PMID: 19067949; http://dx.doi.org/10.1111/j.1751-097.2008.00468.x
  • Donnelly RF, McCarron PA, Lightowler JM, Woolfson AD. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis. J Control Release 2005; 103:381 - 392; PMID: 15763621; http://dx.doi.org/10.1016/j.jconrel.2004.12.005
  • Calzavara-Pinton PG, Venturini M, Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B 2005; 78:1 - 6; PMID: 15629243; http://dx.doi.org/10.1016/j.jphotobiol.2004.06.006
  • Gonzales FP, da Silva SH, Roberts DW, Braga GU. Photodynamic inactivation of conidia of the fungi Metarhizium anisopliae and Aspergillus nidulans with methylene blue and toluidine blue. Photochem Photobiol 2010; 86:653 - 661; PMID: 20113427; http://dx.doi.org/10.1111/j.1751-097.2009.00689.x
  • Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007; 128:1037 - 1050; PMID: 17382878; http://dx.doi.org/10.1016/j.cell.2007.03.004
  • Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006; 19:382 - 402; PMID: 16614254; http://dx.doi.org/10.1128/CMR.19.2.382-402.2006
  • Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, et al. Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 2009; 22:291 - 321; PMID: 19366916; http://dx.doi.org/10.1128/CMR.00051-08
  • Tegos G. Carpinella C, Rai M. Natural substrates and inhibitors of multidrug resistant pumps (MDRs) redefine the plant antimicrobials in naturally occurring bioactive compounds: a new and safe alternative for control of pests and microbial diseases 2006; Cambridge University Press
  • Tegos GP, Hamblin MR. Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob Agents Chemother 2006; 50:196 - 203; PMID: 16377686; http://dx.doi.org/10.1128/AAC.50.1.196-203.2006
  • Prates RA, Kato IT, Ribeiro MS, Tegos GP, Hamblin MR. Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J Antimicrob Chemother 2011; 66:1525 - 1532; PMID: 21525022; http://dx.doi.org/10.1093/jac/dkr160
  • Tatsumi R, Wachi M. TolC-dependent exclusion of porphyrins in Escherichia coli. J Bacteriol 2008; 190:6228 - 6233; PMID: 18641137; http://dx.doi.org/10.1128/JB.00595-08
  • Fernandez A, Lechardeur D, Derré-Bobillot A, Couvé E, Gaudu P, Gruss A. Two coregulated efflux transporters modulate intracellular heme and protoporphyrin IX availability in Streptococcus agalactiae. PLoS Pathog 2010; 6:1000860; PMID: 20421944; http://dx.doi.org/10.1371/journal.ppat.1000860
  • Morgan J, Jackson JD, Zheng X, Pandey SK, Pandey RK. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy. Mol Pharm 2010; In press PMID: 20684544; http://dx.doi.org/10.1021/mp100154j
  • Grinholc M, Zawacka-Pankau J, Gwizdek-Wisniewska A, Bielawski KP. Evaluation of the role of the pharmacological inhibition of Staphylococcus aureus multidrug resistance pumps and the variable levels of the uptake of the sensitizer in the strain-dependent response of Staphylococcus aureus to PPArg(2)-based photodynamic inactivation. Photochem Photobiol 2010; 86:1118 - 1126; PMID: 20630028; http://dx.doi.org/10.1111/j.1751-097.2010.00772.x
  • Tegos GP, Haynes M, Strouse JJ, Khan MMT, Bologa CG, Oprea TI, et al. Microbial efflux inhibition; tactics & strategies. Curr Pharm Des 2011; In press PMID: 21470111
  • Tegos GP, Masago K, Aziz F, Higginbotham A, Stermitz FR, Hamblin MR. Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob Agents Chemother 2008; 52:3202 - 3209; PMID: 18474586; http://dx.doi.org/10.1128/AAC.00006-08
  • Bornstein E, Hermans W, Gridley S, Manni J. Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures. Photochem Photobiol 2009; 85:1364 - 1374; PMID: 19709379; http://dx.doi.org/10.1111/j.1751-097.2009.00615.x
  • Bornstein E, Gridley S, Wengender P, Robbins A. Photodamage to multidrug-resistant gram-positive and gram-negative bacteria by 870 nm/930 nm light potentiates erythromycin, tetracycline and ciprofloxacin. Photochem Photobiol 2010; 86:617 - 627; PMID: 20408973; http://dx.doi.org/10.1111/j.1751-097.2010.00725.x
  • Pflumm M. Caught on film. Nat Med 2011; 17:650 - 653; PMID: 21647135; http://dx.doi.org/10.1038/nm0611-650
  • Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001; 45:999 - 1007; PMID: 11257008; http://dx.doi.org/10.1128/AAC.45.4.999-1007.2001
  • Biel MA. Photodynamic therapy of bacterial and fungal biofilm infections. Methods Mol Biol 2010; 635:175 - 194; PMID: 20552348; http://dx.doi.org/10.1007/978-1-60761-697-9_13
  • Gad F, Zahra T, Hasan T, Hamblin MR. Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother 2004; 48:2173 - 2178; PMID: 15155218; http://dx.doi.org/10.1128/AAC.48.6.2173-8.2004
  • Sharma M, Visai L, Bragheri F, Cristiani I, Gupta PK, Speziale P. Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother 2008; 52:299 - 305; PMID: 17967908; http://dx.doi.org/10.1128/AAC.00988-07
  • Lin HY, Chen CT, Huang CT. Use of merocyanine 540 for photodynamic inactivation of Staphylococcus aureus planktonic and biofilm cells. Appl Environ Microbiol 2004; 70:6453 - 6458; PMID: 15528505; http://dx.doi.org/10.1128/AEM.70.11.6453-8.2004
  • Sbarra MS, Di Poto A, Arciola CR, Saino E, Sharma M, Bragheri F, et al. Photodynamic action of merocyanine 540 on Staphylococcus epidermidis biofilms. Int J Artif Organs 2008; 31:848 - 857; PMID: 18924098
  • Di Poto A, Sbarra MS, Provenza G, Visai L, Speziale P. The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials 2009; 30:3158 - 166; PMID: 19329182; http://dx.doi.org/10.1016/j.biomaterials.2009.02.038
  • Sbarra MS, Arciola CR, Di Poto A, Saino E, Rohde H, Speziale P, et al. The photodynamic effect of tetra-substituted N-methyl-pyridyl-porphine combined with the action of vancomycin or host defense mechanisms disrupts Staphylococcus epidermidis biofilms. Int J Artif Organs 2009; 32:574 - 583; PMID: 19856267
  • Saino E, Sbarra MS, Arciola CR, Scavone M, Bloise N, Nikolov P, et al. Photodynamic action of Tri-meso (N-methyl-pyridyl), meso (N-tetradecyl-pyridyl) porphine on Staphylococcus epidermidis biofilms grown on Ti6A14V alloy. Int J Artif Organs 2010; 33:636 - 645; PMID: 20963728
  • Zanin IC, Gonçalves RB, Junior AB, Hope CK, Pratten J. Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother 2005; 56:324 - 330; PMID: 15983029; http://dx.doi.org/10.1093/jac/dki232
  • Zanin IC, Lobo MM, Rodrigues LK, Pimenta LA, H”fling JF, Gonçalves RB. Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur J Oral Sci 2006; 114:64 - 69; PMID: 16460343; http://dx.doi.org/10.1111/j.1600-0722.2006.00263.x
  • Wood S, Metcalf D, Devine D, Robinson C. Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J Antimicrob Chemother 2006; 57:680 - 684; PMID: 16464894; http://dx.doi.org/10.1093/jac/dkl021
  • Metcalf D, Robinson C, Devine D, Wood S. Enhancement of erythrosine-mediated photodynamic therapy of Streptococcus mutans biofilms by light fractionation. J Antimicrob Chemother 2006; 58:190 - 192; PMID: 16735434; http://dx.doi.org/10.1093/jac/dkl205
  • Goulart Rde C, Bolean M, Paulino Tde P, Thedei G Jr, Souza SL, Tedesco AC, et al. Photodynamic therapy in planktonic and biofilm cultures of Aggregatibacter actinomycetemcomitans. Photomed Laser Surg 2010; 28:53 - 60; PMID: 19780630
  • Nastri L, Donnarumma G, Porzio C, De Gregorio V, Tufano MA, Caruso F, et al. Effects of toluidine blue-mediated photodynamic therapy on periopathogens and periodontal biofilm: in vitro evaluation. Int J Immunopathol Pharmacol 2010; 23:1125 - 1132; PMID: 21244761
  • Lee CF, Lee CJ, Chen CT, Huang CT. delta-Aminolaevulinic acid mediated photodynamic antimicrobial chemotherapy on Pseudomonas aeruginosa planktonic and biofilm cultures. J Photochem Photobiol B 2004; 75:21 - 25; PMID: 15246346; http://dx.doi.org/10.1016/j.jphotobiol.2004.04.003
  • Collins TL, Markus EA, Hassett DJ, Robinson JB. The effect of a cationic porphyrin on Pseudomonas aeruginosa biofilms. Curr Microbiol 2010; 61:411 - 416; PMID: 20372908; http://dx.doi.org/10.1007/s00284-010-9629-y
  • Fontana CR, Abernethy AD, Som S, Ruggiero K, Doucette S, Marcantonio RC. The antibacterial effect of photodynamic therapy in dental plaque-derived biofilms. J Periodontal Res 2009; 44:751 - 759; PMID: 19602126; http://dx.doi.org/10.1111/j.1600-0765.2008.01187.x
  • Raghavendra M, Koregol A, Bhola S. Photodynamic therapy: a targeted therapy in periodontics. Aust Dent J 2009; 54:102 - 109; PMID: 19737261; http://dx.doi.org/10.1111/j.1834-7819.2009.01148.x
  • Soukos NS, Chen PS, Morris JT, Ruggiero K, Abernethy AD, Som S. Photodynamic therapy for endodontic disinfection. J Endod 2006; 32:979 - 984; PMID: 16982278; http://dx.doi.org/10.1016/j.joen.2006.04.007
  • Bisland SK, Chien C, Wilson BC, Burch S. Preclinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis. Photochem Photobiol Sci 2006; 5:31 - 38; PMID: 16395425; http://dx.doi.org/10.1039/b507082a
  • Donnelly RF, McCarron PA, Cassidy CM, Elborn JS, Tunney MM. Delivery of photosensitisers and light through mucus: investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection. J Control Release 2007; 117:217 - 226; PMID: 17196290; http://dx.doi.org/10.1016/j.jconrel.2006.11.010
  • Schuckert KH, Jopp S, Muller U. De novo grown bone on exposed implant surfaces using photodynamic therapy and recombinant human bone morphogenetic protein-2: case report. Implant Dent 2006; 15:361 - 365; PMID: 17172953; http://dx.doi.org/10.1097/01.id.0000247856.09740.3f
  • Donnelly RF, McCarron PA, Tunney MM, Woolfson AD. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J Photochem Photobiol B 2007; 86:59 - 69; PMID: 16963273; http://dx.doi.org/10.1016/j.jphotobiol.2006.07.011
  • D”rtbudak O, Haas R, Bernhart T, Mailath-Pokorny G. Lethal photosensitization for decontamination of implant surfaces in the treatment of periimplantitis. Clin Oral Implants Res 2001; 12:104 - 108; PMID: 11251658; http://dx.doi.org/10.1034/j.1600-0501.2001.012002104.x
  • Demidova TN, Hamblin MR. Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol 2005; 71:6918 - 6925; PMID: 16269726; http://dx.doi.org/10.1128/AEM.71.11.6918-25.2005
  • Oliveira A, Almeida A, Carvalho CM, Tome JP, Faustino MA, Neves MG, et al. Porphyrin derivatives as photosensitizers for the inactivation of Bacillus cereus endospores. J Appl Microbiol 2009; 106:1986 - 1995; PMID: 19228253; http://dx.doi.org/10.1111/j.1365-2672.2009.04168.x
  • Kim BY, Rutka JT, Chan WCW. Nanomedicine. N Engl J Med 2010; 363:2434 - 2443; PMID: 21158659; http://dx.doi.org/10.1056/NEJMra0912273
  • Perni S, Prokopovich P, Pratten J, Parkin IP, Wilson M. Nanoparticles: their potential use in antibacterial photodynamic therapy. Photochem Photobiol Sci 2011; 10:712 - 720; PMID: 21380441; http://dx.doi.org/10.1039/c0pp00360c
  • Engelhardt V, Krammer B, Plaetzer K. Antibacterial photodynamic therapy using water-soluble formulations of hypericin or mTHPC is effective in inactivation of Staphylococcus aureus. Photochem Photobiol Sci 2010; 9:365 - 369; PMID: 20221463; http://dx.doi.org/10.1039/b9pp00144a
  • Sibani SA, McCarron PA, Woolfson AD, Donnelly RF. Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. Expert Opin Drug Deliv 2008; 5:1241 - 254; PMID: 18976134; http://dx.doi.org/10.1517/17425240802444673
  • Bombelli C, Bordi F, Ferro S, Giansanti L, Jori G, Mancini G, et al. New cationic liposomes as vehicles of mtetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases. Mol Pharm 2008; 5:672 - 679; PMID: 18507469; http://dx.doi.org/10.1021/mp800037d
  • Ferro S, Ricchelli F, Mancini G, Tognon G, Jori G. Inactivation of methicillin resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents. J Photochem Photobiol B 2006; 83:98 - 104; PMID: 16446097; http://dx.doi.org/10.1016/j.jphotobiol.2005.12.008
  • Tsai T, Yang YT, Wang TH, Chien HF, Chen CT. Improved photodynamic inactivation of Gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg Med 2009; 41:316 - 322; PMID: 19347938; http://dx.doi.org/10.1002/lsm.20754
  • Schwiertz J, Wiehe A, Grafe S, Gitter B, Epple M. Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. Biomaterials 2009; 30:3324 - 3331; PMID: 19304318; http://dx.doi.org/10.1016/j.biomaterials.2009.02.029
  • Guo Y, Rogelj S, Zhang P. Rose Bengal-decorated silica nanoparticles as photosensitizers for inactivation of gram-positive bacteria. Nanotechnology 2010; 21:065102; PMID: 20061596; http://dx.doi.org/10.1088/0957-4484/21/6/065102
  • Jia Y, Joly H, Omri A. Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa. J Liposome Res 2010; 20:134 - 146; PMID: 19831502; http://dx.doi.org/10.3109/08982100903218892
  • Tavares A, Carvalho CM, Faustino MA, Neves MG, Tomé JP, Tomé AC, et al. Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Mar Drugs 2010; 8:91 - 105; PMID: 20161973; http://dx.doi.org/10.3390/md8010091
  • Nakonieczna J, Michta E, Rybicka M, Grinholc M, Gwizdek-Wisniewska A, Bielawski KP. Superoxide dismutase is upregulated in Staphylococcus aureus following protoporphyrin-mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment. BMC Microbiol 2010; 10:323; PMID: 21167031; http://dx.doi.org/10.1186/1471-2180-10-323
  • Brombacher K, Fischer BB, Rüfenacht K, Eggen RI. The role of Yap1p and Skn7p-mediated oxidative stress response in the defence of Saccharomyces cerevisiae against singlet oxygen. Yeast 2006; 23:741 - 750; PMID: 16862604; http://dx.doi.org/10.1002/yea.1392
  • Xavier JB. Social interaction in synthetic and natural microbial communities. Mol Syst Biol 2011; 7:483; PMID: 21487402; http://dx.doi.org/10.1038/msb.2011.16
  • Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol 2007; 5:48 - 56; PMID: 17143318; http://dx.doi.org/10.1038/nrmicro1557
  • Lee YM, Almqvist F, Hultgren SJ. Targeting virulence for antimicrobial chemotherapy. Curr Opin Pharmacol 2003; 3:513 - 519; PMID: 14559097; http://dx.doi.org/10.1016/j.coph.2003.04.001
  • Tubby S, Wilson M, Nair SP. Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent. BMC Microbiol 2009; 9:211; PMID: 19804627; http://dx.doi.org/10.1186/1471-2180-9-211
  • Kömerik N, Wilson M, Poole S. The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol 2000; 72:676 - 680; PMID: 11107854; http://dx.doi.org/10.1562/0031-8655(2000)072<0676:TEOPAO>2.0.CO;2
  • Sharma SK, Dai T, Kharkwal GB, Huang YY, Huang L, De Arce VJ, et al. Drug Discovery of Antimicrobial Photosensitizers using Animal Models. Curr Pharm Des 2011; In press PMID: 21504410
  • St. Denis TG, Huang L, Dai T, Hamblin MR. Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress. Photochem Photobiol 2011; 87:707 - 713; PMID: 21261628; http://dx.doi.org/10.1111/j.1751-097.2011.00902.x
  • Zolfaghari PS, Packer S, Singer M, Nair SP, Bennett J, Street C, et al. In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol 2009; 9:27; PMID: 19193212; http://dx.doi.org/10.1186/1471-2180-9-27
  • Braham P, Herron C, Street C, Darveau R. Antimicrobial photodynamic therapy may promote periodontal healing through multiple mechanisms. J Periodontol 2009; 80:1790 - 1798; PMID: 19905948; http://dx.doi.org/10.1902/jop.2009.090214
  • Fonseca MB, Junior PO, Pallota RC, Filho HF, Denardin OV, Rapoport A, et al. Photodynamic therapy for root canals infected with Enterococcus faecalis. Photomed Laser Surg 2008; 26:209 - 213; PMID: 18484911; http://dx.doi.org/10.1089/pho.2007.2124
  • Soukos NS, Chen PS, Morris JT, Ruggiero K, Abernethy AD, Som S, et al. Photodynamic therapy for endodontic disinfection. J Endod 2006; 32:979 - 984; PMID: 16982278; http://dx.doi.org/10.1016/j.joen.2006.04.007
  • Garcez AS, Ribeiro MS, Tegos GP, Nunez SC, Jorge AO, Hamblin MR. Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med 2007; 39:59 - 66; PMID: 17066481; http://dx.doi.org/10.1002/lsm.20415
  • Schneider S, Carra G, Sahin U, Hoy B, Rieder G, Wessler S. Complex cellular responses of Helicobacter pylori-colonized gastric adenocarcinoma cells. Infect Immun 2011; 79:2362 - 2371; PMID: 21402757; http://dx.doi.org/10.1128/IAI.01350-10
  • Millson CE, Wilson M, MacRobert AJ, Bown SG. Ex-vivo treatment of gastric Helicobacter infection by photodynamic therapy. J Photochem Photobiol B 1996; 32:59 - 65; PMID: 8725054; http://dx.doi.org/10.1016/1011-1344(95)07190-3
  • Wilder-Smith CH, Wilder-Smith P, Grosjean P, van den Bergh H, Woodtli A, Monnier P, et al. Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies. Lasers Surg Med 2002; 31:18 - 22; PMID: 12124710; http://dx.doi.org/10.1002/lsm.10066
  • Hamblin MR, Viveiros J, Yang C, Ahmadi A, Ganz RA, Tolkoff MJ. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother 2005; 49:2822 - 2827; PMID: 15980355; http://dx.doi.org/10.1128/AAC.49.7.2822-7.2005
  • Ganz RA, Viveiros J, Ahmad A, Ahmadi A, Khalil A, Tolkoff MJ, et al. Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 2005; 36:260 - 265; PMID: 15791671; http://dx.doi.org/10.1002/lsm.20161
  • Mihu MR, Martinez LR. Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections. Virulence 2011; 2:97 - 102; PMID: 21321482; http://dx.doi.org/10.4161/viru.2.2.15061
  • Manolakaki D, Velmahos G, Kourkoumpetis T, Chang Y, Alam HB, De Moya MM, et al. Candida infection and colonization among trauma patients. Virulence 2010; 1:367 - 375; PMID: 21178472; http://dx.doi.org/10.4161/viru.1.5.12796
  • Dai T, Kharkwal GB, Tanaka M, Huang YY, Bil de Arce VJ, Hamblin MR. Animal models of external traumatic wound infections. Virulence 2011; 2; In press PMID: 21701256; http://dx.doi.org/10.4161/viru.2.4.16840
  • Maisch T, Bosl C, Szeimies RM, Love B, Abels C. Determination of the antibacterial efficacy of a new porphyrin-based photosensitizer against MRSA ex vivo. Photochem Photobiol Sci 2007; 6:545 - 551; PMID: 17487307; http://dx.doi.org/10.1039/b614770d
  • Hamblin MR, Zahra T, Contag CH, McManus AT, Hasan T. Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis 2003; 187:1717 - 26; PMID: 12751029; http://dx.doi.org/10.1086/375244
  • Wong TW, Wang YY, Sheu HM, Chuang YC. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemothe 2005; 49:895 - 902; PMID: 15728881; http://dx.doi.org/10.1128/AAC.49.3.895-902.2005
  • Dai T, Tegos GP, Lu Z, Huang L, Zhiyentayev T, Franklin MJ, et al. Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother 2009; 53:3929 - 3934; PMID: 19564369; http://dx.doi.org/10.1128/AAC.00027-09
  • Berthiaume F, Reiken SR, Toner M, Tompkins RG, Yarmush ML. Antibody-targeted photolysis of bacteria in vivo. Biotechnology (NY) 1994; 12:703 - 706; PMID: 7764916; http://dx.doi.org/10.1038/nbt0794-703
  • Vilcinskas A. Coevolution between pathogen-derived proteinases and proteinase inhibitors of host insects. Virulence 2010; 1:206 - 14; PMID: 21178444; http://dx.doi.org/10.4161/viru.1.3.12072
  • Fuchs BB, O'Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010; 1:475 - 482; PMID: 21178491; http://dx.doi.org/10.4161/viru.1.6.12985
  • Fuchs BB, Mylonakis E. Using non-mammalian hosts to study fungal virulence and host defense. Curr Opin Microbiol 2006; 9:346 - 51; PMID: 16814595; http://dx.doi.org/10.1016/j.mib.2006.06.004
  • Dutta S, Ongarora BG, Li H, Vicente Mda G, Kolli BK, Chang KP. Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine. PLoS ONE 2011; 6:20786; PMID: 21673971; http://dx.doi.org/10.1371/journal.pone.0020786